相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medication-related osteonecrosis of the jaw: An institution's experience
Mehmet Ali Altay et al.
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE (2020)
Role of Bisphosphonates in Breast Cancer Therapy
Hadar Goldvaser et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study
Alberto Bedogni et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2019)
Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women
Clare J. Wotton et al.
BONE (2019)
Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw
Weiwen Zhu et al.
FASEB JOURNAL (2019)
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study
T. Hasegawa et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Long-term control of Paget's disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a real world setting
Yair Liel et al.
ENDOCRINE (2019)
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma
Andrew J. Yee et al.
FUTURE ONCOLOGY (2018)
Clinical analysis of medication related osteonecrosis of the jaws: A growing severe complication in China
Qizhang Wang et al.
JOURNAL OF DENTAL SCIENCES (2018)
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Noopur Raje et al.
LANCET ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Sakiko Soutome et al.
PLOS ONE (2018)
Multimodal Treatment of Bone Metastasis - A Surgical Perspective
Henry Soeharno et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
Roger von Moos et al.
JOURNAL OF BONE ONCOLOGY (2018)
Bone-Targeted Therapies in Cancer-Induced Bone Disease
Sofia Sousa et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw
Mong-Hun Kang et al.
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS (2018)
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Andrew S. Gdowski et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study
Makoto Kajizono et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Sven Otto et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials
Wei-Xiang Qi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
Michael Gnant et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
Roger von Moos et al.
SUPPORTIVE CARE IN CANCER (2013)
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
F. Saad et al.
ANNALS OF ONCOLOGY (2012)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates
Corey Langer et al.
LUNG CANCER (2010)
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Konstantinos Vahtsevanos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients
Athanassios Kyrgidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment
RE Marx et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
分享论文
